PRE-CLINICAL RESEARCH
Noninvasive Quantification and Optimization of Acute Cell Retention by In Vivo Positron Emission Tomography After Intramyocardial Cardiac-Derived Stem Cell Delivery
John Terrovitis, MD*,
Riikka Lautamäki, MD, PhD ,
Michael Bonios, MD ,
James Fox, BS||,
James M. Engles, MS, MBA ,
Jianhua Yu, BS||,
Michelle K. Leppo, BS ,
Martin G. Pomper, MD, PhD||,
Richard L. Wahl, MD ,
Jurgen Seidel, PhD ,
Benjamin M. Tsui, PhD||,
Frank M. Bengel, MD ,
M. Roselle Abraham, MD and
Eduardo Marbán, MD, PhD*,*
* The Heart Institute, Cedars Sinai Medical Center, Los Angeles, California
Department of Cardiology, Johns Hopkins University, Baltimore, Maryland
Department of Diagnostic Imaging Physics, Johns Hopkins University, Baltimore, Maryland
Department of Nuclear Medicine, Johns Hopkins University, Baltimore, Maryland
|| Department of Radiology, Johns Hopkins University, Baltimore, Maryland
Manuscript received January 2, 2009;
revised manuscript received March 16, 2009,
accepted April 13, 2009.
* Reprint requests and correspondence: Dr. Eduardo Marbán, Director, The Heart Institute, Cedars Sinai Medical Center, 8700 Beverly Boulevard, 1090 Davis Building, Los Angeles, California 90048 (Email: Eduardo.Marban{at}csmc.edu).
Objectives: The aim of this study was to quantify acute myocardial retention of cardiac-derived stem cells (CDCs) and evaluate different delivery methods with positron emission tomography (PET).
Background: Success of stem cell transplantation for cardiac regeneration is partially limited by low retention/engraftment of the delivered cells. A clinically applicable method for accurate quantification of cell retention would enable optimization of cell delivery.
Methods: The CDCs were derived from syngeneic, male Wistar Kyoto (WK) rats labeled with [18F]-fluoro-deoxy-glucose (18FDG) and injected intramyocardially into the ischemic region of female WK rats after permanent left coronary artery ligation. The effects of fibrin glue (FG), bradycardia (adenosine), and cardiac arrest were examined. Imaging with 18FDG PET was performed for quantification of cell retention. Quantitative polymerase chain reaction (PCR) for the male-specific SRY gene was performed to validate the PET results.
Results: Myocardial retention of cells suspended in phosphate-buffered saline 1 h after delivery was 17.6 ± 11.5% by PCR and 17.8 ± 7.3% by PET. When CDCs were injected immediately after induction of cardiac arrest, retention was increased to 75.6 ± 18.6%. Adenosine slowed the ventricular rate and doubled CDC retention (35.4 ± 5.3%). A similar increase in CDC retention was observed after epicardial application of FG at the injection site (37.5 ± 8.2%). The PCR revealed a significant increase in 3-week cell engraftment in the FG animals (22.1 ± 18.6% and 5.3 ± 3.1%, for FG and phosphate-buffered saline, respectively).
Conclusions: In vivo PET permits accurate measurement of CDC retention early after intramyocardial delivery. Sealing injection sites with FG or lowering ventricular rate by adenosine might be clinically translatable methods for improving stem cell engraftment in a beating heart.
Key Words: adenosine cardiac stem cells fibrin glue PET
|
Abbreviations and Acronyms
| | 18FDG = [18F]-fluoro-deoxy-glucose | | BDM = 2,3-butanedione-2-monoxime | | CDC = cardiac-derived stem cells | | CT = computed tomography | | FAC = fractional area change | | FG = fibrin glue | | MI = myocardial infarction | | PBS = phosphate-buffered saline | | PCR = polymerase chain reaction | | PET = positron emission tomography | | qPCR = quantitative polymerase chain reaction | | WKY = Wistar Kyoto |
|
Related Articles
-
Tracking Cell Fate With Noninvasive Imaging
- Gary S. Feigenbaum, Louis Lemberg, and Joshua M. Hare
J. Am. Coll. Cardiol. 2009 54: 1627-1628.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A25.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
K. Malliaras, T.-S. Li, D. Luthringer, J. Terrovitis, K. Cheng, T. Chakravarty, G. Galang, Y. Zhang, F. Schoenhoff, J. Van Eyk, et al.
Safety and Efficacy of Allogeneic Cell Therapy in Infarcted Rats Transplanted With Mismatched Cardiosphere-Derived Cells
Circulation,
January 3, 2012;
125(1):
100 - 112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. H. Wu, X. M. Mo, Z. C. Han, and B. Zhou
Stem Cell Engraftment and Survival in the Ischemic Heart
Ann. Thorac. Surg.,
November 1, 2011;
92(5):
1917 - 1925.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. F. M. Segers and R. T. Lee
Biomaterials to Enhance Stem Cell Function in the Heart
Circ. Res.,
September 30, 2011;
109(8):
910 - 922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. K. Nguyen, F. Lan, Y. Wang, and J. C. Wu
Imaging: Guiding the Clinical Translation of Cardiac Stem Cell Therapy
Circ. Res.,
September 30, 2011;
109(8):
962 - 979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. White, R. R. Smith, S. Matsushita, T. Chakravarty, L. S. C. Czer, K. Burton, E. R. Schwarz, D. R. Davis, Q. Wang, N. L. Reinsmoen, et al.
Intrinsic cardiac origin of human cardiosphere-derived cells
Eur. Heart J.,
June 9, 2011;
(2011)
ehr172v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Malliaras and E. Marban
Cardiac cell therapy: where we've been, where we are, and where we should be headed
Br. Med. Bull.,
June 1, 2011;
98(1):
161 - 185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tongers, D. W. Losordo, and U. Landmesser
Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges
Eur. Heart J.,
May 2, 2011;
32(10):
1197 - 1206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Sturzu and S. M. Wu
Developmental and Regenerative Biology of Multipotent Cardiovascular Progenitor Cells
Circ. Res.,
February 4, 2011;
108(3):
353 - 364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-T. Lee, A. J. White, S. Matsushita, K. Malliaras, C. Steenbergen, Y. Zhang, T.-S. Li, J. Terrovitis, K. Yee, S. Simsir, et al.
Intramyocardial Injection of Autologous Cardiospheres or Cardiosphere-Derived Cells Preserves Function and Minimizes Adverse Ventricular Remodeling in Pigs With Heart Failure Post-Myocardial Infarction
J. Am. Coll. Cardiol.,
January 25, 2011;
57(4):
455 - 465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Li, S. Zuo, Z. He, Y. Yang, Z. Pasha, Y. Wang, and M. Xu
Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival
Am J Physiol Heart Circ Physiol,
December 1, 2010;
299(6):
H1772 - H1781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Osborn and F. A. Jaffer
The Year in Molecular Imaging
J. Am. Coll. Cardiol. Img.,
November 1, 2010;
3(11):
1181 - 1195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Cheng, T. S. Li, K. Malliaras, D. R. Davis, Y. Zhang, and E. Marban
Magnetic Targeting Enhances Engraftment and Functional Benefit of Iron-Labeled Cardiosphere-Derived Cells in Myocardial Infarction
Circ. Res.,
May 28, 2010;
106(10):
1570 - 1581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Marban and K. Cheng
Heart to Heart: The Elusive Mechanism of Cell Therapy
Circulation,
May 11, 2010;
121(18):
1981 - 1984.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Wu, M. R. Abraham, and D. L. Kraitchman
Current Perspectives on Imaging Cardiac Stem Cell Therapy
J. Nucl. Med.,
May 1, 2010;
51(Supplement_1):
128S - 136S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. O'Blenes, A. W. Li, R. Chen, R. C. Arora, and M. Horackova
Engraftment Is Optimal When Myoblasts Are Transplanted Early: The Role of Hepatocyte Growth Factor
Ann. Thorac. Surg.,
March 1, 2010;
89(3):
829 - 835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. V. Terrovitis, R. R. Smith, and E. Marban
Assessment and Optimization of Cell Engraftment After Transplantation Into the Heart
Circ. Res.,
February 19, 2010;
106(3):
479 - 494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, G. K. Feld, B. H. Greenberg, J. Hall, M. Hlatky, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, et al.
Highlights of the Year in JACC 2009
J. Am. Coll. Cardiol.,
January 26, 2010;
55(4):
380 - 407.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Feigenbaum, L. Lemberg, and J. M. Hare
Tracking Cell Fate With Noninvasive Imaging
J. Am. Coll. Cardiol.,
October 20, 2009;
54(17):
1627 - 1628.
[Full Text]
[PDF]
|
 |
|
|